High Bone Mineral Density: Real or Masking a Bone Fragility?

Research Article

J Dent & Oral Disord. 2017; 3(5): 1074.

High Bone Mineral Density: Real or Masking a Bone Fragility?

Fighera TM¹, Silva RP¹, Pinto JVM¹, Cardenaz GS², Moreira CA¹ and Borba VZC¹*

¹Endocrinology and Metabology Service, Hospital de Clinicas, Federal University of Paraná, Brazil

²Martins e Godoy Medicina Diagnóstica, Belo Horizonte, Minas Gerais

*Corresponding author: Victoria Zeghbi Cochenski Borba, Endocrinology and Metabology Service, Hospital de Clinicas, Federal University of Paraná, Brazil

Received: September 05, 2017; Accepted: October 13, 2017; Published: October 20, 2017


Objective: The aim of this study is to evaluate individuals with high BMD and correlate with clinical and laboratory parameters.

Methods: We performed a search over the last 4 years, in the boned ensitometry database of the endocrinology unit (Hospital de Clinic as, Federal University of Parana), searching for Z-score = 2.0 SD in spine or femur. After selection, we reviewed the medical records of each patient, evaluating their co morbidities and medical history, In a subgroup of patients, we performed an analysis of trabecular bone score.

Results: 104 patients were included, the mean age was 62 years, majorities (96%) were women. A significant correlation between the presence of artifacts and altered BMD (p <0.001) was observed. In patients with high bone density in spine, approximately 58% had osteopenia or osteoporosis at one or more sites evaluated, whereas in patients with arthrosis in spine, 68% had a diagnosis of osteoporosis or osteopenia. Furthermore, a correlation between artifacts and Z-score = 2.0 SD in the femoral neck was found (p = 0.008). Of all co morbidities analyzed, there was an association between hypertension and presence of artifacts (p <0.001), such as arthrosis and scoliosis. It was also observed that 72% of patients with hypothyroidism had artifacts (p=0.014).The analysis of trabecular bone score was performed in a subgroup of 21 postmenopausal women, and damage to the micro architecture was observed in 39% of patients with normal densitometry.

Discussion & Conclusion: We found a high prevalence of patients with high bone mass in one site and diagnosis of osteopenia / osteoporosis with micro architecture damage. These results show that patients with artifacts in the densitometry exam need a more careful evaluation.

Keywords: Artifacts; High bone mineral density; Osteopenia; Osteoporosis


The World Health Organization defines the presence of osteoporosis in postmenopausal women as a Bone Mineral Density (BMD) less than or equal to 2.5 standard deviation (SD) (T score -2.5) compared to young women, assessed by densitometry of lumbar spine, femur, or forearm [1]. In this context, bone density is considered normal when it is greater than or equal to -1.0 standard deviation (T-score -1.0) [2]. However, there is no cut-off point above which bone density can be determined as abnormally high, meaning that T-score values equal to or greater than 4 to 5 SD, for example, are not clinically appreciated. It is known that degenerative diseases, vascular calcifications, and compression fractures can lead to localized increase in BMD. On the other hand, when the increase in BMD is widespread, it may be associated with genetic disorders, and a variety of endocrine, metabolic, infectious, or neoplastic diseases [3].

In a consensus published in 2007, the International Society for Clinical Densitometry concluded that it is not possible to establish a cut-off point for high BMD since there is insufficient evidence to determine whether a person with high BMD has some underlying disease or higher risk of fracture [2]. Whyte [3] suggested that the Z-score, not the T-score, is better to evaluate high BMD, with a threshold = 2.5 SD. The Canadian consensus also suggests that a Z-score above 2.5 should not be considered normal [4]. Thus, if a Z-score = 2.5 DP is used to define high BMD, the estimated prevalence is 6.2/1000, while a Z-score = 4 SD identifies approximately 3/1000, significantly decreasing the prevalence of this finding [5].

Multiple causes of high BMD that have been identified include artifacts, fractures, ligament calcification, degenerative changes [2], diffuse idiopathic hyperostosis [6], aortic calcification, and osteoarthritis [7]. However, until now, no consensus has been reached on the definition of high bone density and its clinical significance.

Despite the BMD measurement being recommended to evaluate the risk of fracture, it does not directly reflect the deterioration in bone micro architecture. The Trabecular Bone Score (TBS) is a noninvasive technique that can be applied to X-ray images by quantifying local variations in gray level. It is comparable to BMD to predict fractures, and the combination was superior to either measurement alone [8]. Furthermore, TBS is an indirect measurement of trabecular micro architecture that is not affected by lumbar osteoarthritis [9,10].

The aim of this study is to evaluate the clinical profile of individuals with high BMD and correlate it with laboratory tests, TBS and presence of artifacts in bone densitometry.

Materials and Methods

We evaluated all Bone Mineral Density (BMD) exams performed between January 2009 to December 2012 in the endocrinology unit, Hospitalde Clinicas (UFPR), searching for results with Z-score = 2.0 SD in lumbar spine and/or femur. Inclusion criteria were men and women between 20 and 88 years; with medical records available at the hospital file; and not currently participating in clinical research. From medical records were collected anthropometric data, history of physical activity, smoking and past fractures, presence of co morbidities (analyzed only when present in two or more patients), and possible co morbidities that could be associated with a high BMD in medical history. Laboratory tests such as measurement of serum calcium, phosphorus, albumin, creatinine, 25 hydroxy-vitamins D (25OHD), and Parathormone (PTH) were also evaluated. The same technician performed the BMD tests by Dual Energy X-Ray Absorptiometry (DXA) on a Lunar Prodigy whole-body scanner (GE Medical Systems, Madison, WI, USA).TBS was performed in a subgroup of postmenopausal women with available lumbar spine densitometry.

Images of densitometry were reanalyzed and patients classified according to the presence of possible artifacts in the lumbar spine, such as presence of degenerative disease (osteoarthritis), scoliosis, or both, or any visible artifact that could be characterized as a factor for increasing bone mass. Subsequently, we classified patients based on the Final Densitometric Diagnosis (FDD) as normal, osteopenia, and osteoporosis, according to WHO and ISCD criteria (International Society for Clinical Densitometry), and above normal when the Z score was = +2.0SD in at least two sites analyzed.

Statistical analysis

Data were entered in Excel and then exported to SPSS v.18.0 for statistical analysis. Categorical variables were reported as frequencies and percentages. Quantitative variables with normal distributions were described by mean and standard deviation, and the asymmetric distribution with the median and inter quartile range (25th and 75th percentiles). Categorical variables were associated with the Chisquare test or Fisher’s exact test. Quantitative variables with normal distributions were compared by Analysis of Variance (ANOVA) followed by Tukey’s post hoctest to locate differences. Quantitative variables with asymmetric distribution were compared between two categories using the Mann-Whitney test and between three categories using the Kruskal-Wallis test. To assess the correlation between quantitative variables, the Pearson correlation coefficient was used, with the significance level set at 5%.


The final sample included 104 patients with mean age of 62.4±14.3 years, 96% were women. The mean weight was 70.3±14.5 kg, and the body mass index (BMI) was 29±5.5 kg/m². Most patients were Caucasian (99%), and 11% were smokers. Of the total sample, only 9 patients (9%) practiced regular physical activity, considered at least30minutes of daily exercise. Half of the patients used some treatment for osteoporosis, especially bisphosphonates, approximately 20% had used or were using glucocorticoids, and 13% were taking hormone replacement therapy.

Degenerative disease [arthrosis] (40%), scoliosis (3%), or both (12%) were the artifacts present in this sample. The mean BMD in the lumbar spine was 1.447 ± 0.219 g/cm²; in the femoral neck, 1.019 ± 0.272 g/cm²; and in the forearm, 0.766 ± 0.129 g/cm². When evaluated the FDD, 60 individuals (57.6%) had low bone mass reported in another site, being 41 (39.4%) and 19 (18.2%) with osteopenia and osteoporosis, respectively. When patients with artifacts in the lumbar spine were excluded, only 24.2% had osteopenia and 6.1% had osteoporosis at the FDD. Low bone mass was present in 68.5% of the 42 patients with vertebral arthrosis (51.4% had osteopenia and 17.1% had osteoporosis at the FDD), with a significant association between the presence of artifact and low bone mass in the FDD (p<0.001). No association was found between the presence of artifacts in lumbar spine and the Z-score > 2.0 SD in this site (p = 0.537) or in the total hip (p = 0.299). However, a significant association was found between the presence of artifacts and Z-score > 2.0 SD in the femoral neck (p = 0.008). Only 25% of the patients without a diagnosis of arthrosis showed high BMD.

Significant differences were found among age, weight, and BMI according to the FDD (Table1). No significant association was found between the FDD and other clinical parameters evaluated. Patients with high bone mass had a higher number of co morbidities (p= 0.018). Of all co morbidities observed, there was an association between hypertension and hypothyroidism and the presence of artifacts (Table 2). About 72% of patients with hypothyroidism had artifacts, but not higher BMD. No association was found between the final diagnosis and medications for osteoporosis or abnormal laboratory test (p =0.381 and p= respectively).

Citation:Fighera TM, Silva RP, Pinto JVM, Cardenaz GS, Moreira CA and Borba VZC. High Bone Mineral Density: Real or Masking a Bone Fragility?. J Dent & Oral Disord. 2017; 3(5): 1074. ISSN:2572-7710